Professor Martyn Kirk (Co-Chair)

BAppSci (WIAE), MAppEpid (ANU), PhD (ANU) NHMRC Career Development Fellow College of Health & Medicine

Martyn has worked for over twenty years in State, Territory and federal health departments in the areas of food, water and infectious diseases. Previously, he ran the Australian Field Epidemiology Training Program - the Master of Philosophy in Applied Epidemiology (MAE) program - and the Australian network for foodborne disease investigation - OzFoodNet. Martyn consulted for the World Health Organization on gastrointestinal diseases and is a member of the WHO advisory body - the Foodborne Disease Epidemiology Reference Group. Martyn is an adjunct lecturer at the Monash University Department of Epidemiology and Preventive Medicine. He holds research grants with the National Health & Medical Research Council, the Australian Research Council, and governments within Australia.

Professor Katie Flanagan (Co-Chair)

Professor, Immunology Alfred Hospital, Monash University

Professor Katie Flanagan is a clinician scientist who has worked on global health issues for more than 20 years. She is Head of Infectious Diseases at Launceston General Hospital where her department provides a clinical infectious diseases service for the population of North and NW Tasmania. She is affiliated to University of Tasmania, Monash University and RMIT where she is conducting a number of research projects. Her main research interests are in the fields of vaccinology and infectious diseases immunology.  She has led numerous vaccine immunology trials throughout the world including trials of novel malaria and HIV vaccines in African infants, and trials of the immunological effects of commonly used vaccines in the young and elderly. Her current main research focus involves applying systems biology techniques to study human responses to vaccination particularly at the extremes of age; and the role that biological sex plays in the vaccine-specific responses and non-targeted effects of vaccines.

Mr Terry Slevin

CEO, Public Health Association of Australia

Terry Slevin has been Chief Executive Office for the Public Health Association of Australia (PHAA) since May 2018.  He is Adjunct Professor in the School of Psychology at Curtin University an Adjunct Professor in the College of Health and Medicine at the Australian National University.  He is a Fellow of PHAA and was the first Vice President (Development) of the Association.


Adj Prof Slevin is a regular media commentator on all aspects of public health and cancer, ranging from causes and early detection, to broader chronic disease prevention including nutrition, physical activity, weight control, alcohol, sun protection and gun control.  He also has a special interest in Occupational and environmental cancer risks.


Until April 2018 he was Director, Education and Research at Cancer Council WA where he worked since 1994. Mr Slevin holds a Masters in Public Health and an Honours degree in Psychology.

As well as serving as Chair of Cancer Council Australia’s Occupational and Environmental Cancer Risk Committee, Mr Slevin has previously chaired Cancer Council's Skin Cancer Committee and was founding Chair of Nutrition and Physical Activity Committee, where he served for 10 years.  He has contributed to the planning of the Union for International Cancer Control (UICC) World Cancer Congress from 2012 to 2016 and was Co Chair of the Scientific Committee for the World Cancer Congress in Kuala Lumpur in 2018.

He is the editor of a book on skin cancer Sun, Skin and Health, released by CSIRO Publishing in 2014 and has published over 70 papers in the peer reviewed literature and a series of 15 articles on cancer myths.  


His current focus is on promoting evidence based public health policy in Australia with a focus on equity and improved health outcomes for the most disadvantaged Australians.

Professor Jodie McVernon

Professor and Director of Doherty Epidemiology, Doherty Institute

Professor Jodie McVernon is a physician with subspecialty qualifications in public health and vaccinology. She has extensive expertise in clinical vaccine trials, epidemiologic studies and mathematical modelling of infectious diseases, gained at the University of Oxford, Health Protection Agency London and The University of Melbourne. Her work focuses on the application of a range of cross-disciplinary methodological approaches including mathematical and computational models, to synthesise insights from basic biology, epidemiological data and sociological research. These models advance understanding of the observed epidemiology of infectious diseases and inform understanding of optimal interventions for disease control.

Dr Trent Yarwood

Infectious Diseases Physician, Senior Lecturer, James Cook University and, The University of Queensland

Trent is an infectious diseases physician, and the clinical director of the Queensland Statewide Antimicrobial Stewardship program. His clinical interests include the public health management of drug-resistant infection, infection control, HIV medicine and digital health.

He is a senior lecturer at James Cook University, Cairns and the Rural Clinical School of the University of Queensland, and senior health advisor for Future Wise Australia.

Professor Allen Cheng

Professor (Research), Epidemiology and Preventive Medicine Alfred Hospital, Monash University

Prof Allen Cheng is an infectious diseases physician. He is Professor of Infectious Diseases Epidemiology and is Director of the Infection Prevention and Healthcare Epidemiology unit at Alfred Health. He has a PhD (Flinders University), a Master of Public Health (Monash University) and a Master of Biostatistics (University of Queensland). He has previously worked as an infectious diseases and general physician in Darwin and Geelong, and has worked in remote communities in the Top End of Australia, and in Papua New Guinea, Thailand, the United States and Finland.

His research covers a diverse area within infectious diseases, including sepsis and severe melioidosis, tropical medicine, influenza and vaccine effectiveness, hospital infection prevention and control, antibiotic pharmacokinetics, antimicrobial drug policy and clinical infectious diseases. He has published over 280 peer-reviewed scientific publications (as well as >50 letters/editorials and 17 book chapters).

Prof Cheng is current Vice-President of the Australasian Society for Infectious Diseases (ASID); he was the primary author for national guidelines for H1N1/09 influenza and Clostridium difficile infection; a foundation member of the Clinical Research Network of ASID; a steering committee member for the National Prescribing Service Antibiotic Resistance initiative; and a member of expert writing groups for Therapeutic Guidelines: Antibiotic and Respiratory. He is a member of the Expert Advisory Group revising the Australian Infection Control Guidelines for NHMRC. 

Associate Professor Linda Selvey

Associate Professor School of Public Health, The University of Queensland

Associate Professor Linda Selvey has joined the School of Public Health as a Teaching and Research Academic. Linda is the immediate past President of AFPHM and chair of PHAA’s CTERC. She is a public health physician and her main research area is infectious disease. Her research interests are diverse including: climate change; Clostridium difficile, a bacterium that can cause severe diarrhea in vulnerable people; sexual health; blood borne viruses and antimicrobial resistance.

A/Prof Selvey formerly worked for Queensland Health, starting there as Director of Communicable Diseases Branch in December 1996 and in 2005,  then promoted to Executive Director, Population Health Queensland. She remained in this position until moving to Sydney where she took up the position of CEO of Greenpeace Australia Pacific. A/Prof Selvey then moved to Perth to join her partner and worked at Curtin University, School of Public Health, before joining The University of Queensland.

Professor James Ward

Director, UQ Poche Centre, UQ Poche Centre for Indigenous Health, School of Public Health, University of Queensland

Professor James Ward is a Pitjantjatjara and Narungga man, and a national leader in Aboriginal and Torres Strait Islander research. He is currently the Director of the Poche Centre for Indigenous Health and Professor within the School of Public Health at the University of Queensland. As such he leads a research program focused on urban Aboriginal and Torres Strait Islander health and an infectious diseases research program and associated issues through the School of Public Health.


Having held various roles in Aboriginal public health policy for both government and non-government organisations, in 2007 he was appointed as the Inaugural Program Head of the Aboriginal Program at the Kirby Institute, University of New South Wales. In 2012 he moved to Alice Springs to become Deputy Director of the Baker Institutes' Aboriginal Health Program, after which he joined the South Australian Health and Medical Research Institute. James has been awarded funding applications totalling $23M since 2013; including $7.14M as CIA on NHMRC funded grants and has authored 130 publications. He has led national research projects on health services research; in health promotion; and methamphetamines to name a few.

His work has influenced policy and practice significantly contributing to national guidelines, policy and practice. During 2020 he has contributed to the national COVID—19 response nationally through membership of the Communicable Diseases Network of Australia and the National Aboriginal and Torres Strait Islander COVID-19 Taskforce.

Associate Professor Joseph Doyle

Associate Professor of Infectious Diseases, The Alfred and Monash Univerity, Deputy Director, Diseases Elimination Program, Burnet Institute

Joseph is a clinician-researcher and dual-trained infectious diseases and public health physician. He has a particular interest in the epidemiology, management and prevention of blood borne viruses.

With a background in clinical medicine, Joseph specialised in infectious diseases at the Alfred where he works as a physician. He completed his MPH at the London School of Hygiene and Tropical Medicine and his public health fellowship was undertaken at the Victorian Infectious Diseases Reference Laboratory and Burnet Institute. His PhD at Monash School of Population Health was focused on improving hepatitis C care and management.

Joseph is currently NHMRC Career Developement Fellow and Associate Professor in the Department of Infectious Diseases at The Alfred and Monash University, clinical lead for Population Health at Alfred Health, and jointly appointed as Deputy Director of Disease Elimination Program at Burnet Institute. He is also a member of ASID Board and chairs ASID’s virology committee. 

Please reload